Ortiz Rojas, C.A.; Costa-Neto, A.; Pereira-Martins, D.A.; Le, D.M.; Sternadt, D.; Weinhäuser, I.; Huls, G.; Schuringa, J.J.; Magalhães Rego, E.
High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia. Cancers 2023, 15, 296.
https://doi.org/10.3390/cancers15010296
AMA Style
Ortiz Rojas CA, Costa-Neto A, Pereira-Martins DA, Le DM, Sternadt D, Weinhäuser I, Huls G, Schuringa JJ, Magalhães Rego E.
High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia. Cancers. 2023; 15(1):296.
https://doi.org/10.3390/cancers15010296
Chicago/Turabian Style
Ortiz Rojas, César Alexander, Abel Costa-Neto, Diego A. Pereira-Martins, Duy Minh Le, Dominique Sternadt, Isabel Weinhäuser, Gerwin Huls, Jan Jacob Schuringa, and Eduardo Magalhães Rego.
2023. "High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia" Cancers 15, no. 1: 296.
https://doi.org/10.3390/cancers15010296
APA Style
Ortiz Rojas, C. A., Costa-Neto, A., Pereira-Martins, D. A., Le, D. M., Sternadt, D., Weinhäuser, I., Huls, G., Schuringa, J. J., & Magalhães Rego, E.
(2023). High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia. Cancers, 15(1), 296.
https://doi.org/10.3390/cancers15010296